These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7641085)

  • 1. Financing of end-stage renal disease care: past, present, and future.
    Farley DO
    Adv Ren Replace Ther; 1994 Apr; 1(1):24-31. PubMed ID: 7641085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The organization and financing of kidney dialysis and transplant care in the United States of America.
    Hirth RA
    Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and directions for Medicare ESRD payment policy.
    Ray NF; Ross M
    Semin Nephrol; 2000 Nov; 20(6):565-76. PubMed ID: 11111858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does One Size Fit All With the Effects of Payment Reform? Dialysis Facility Payer Mix and Anemia Management Under the Expanded Medicare Prospective Payment System.
    Mukhopadhyay P; Pearson J; Cogan C; Gaber C; Gillespie BW; Turenne M
    Med Care; 2019 Aug; 57(8):584-591. PubMed ID: 31295188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare Program; End-Stage Renal Disease Prospective Payment System, Coverage and Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program Bid Surety Bonds, State Licensure and Appeals Process for Breach of Contract Actions, Durable Medical Equipment, Prosthetics, Orthotics and Supplies Competitive Bidding Program and Fee Schedule Adjustments, Access to Care Issues for Durable Medical Equipment; and the Comprehensive End-Stage Renal Disease Care Model. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2016 Nov; 81(214):77834-969. PubMed ID: 27905888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Payment Reform and Health Disparities: Changes in Dialysis Modality under the New Medicare Dialysis Payment System.
    Turenne M; Baker R; Pearson J; Cogan C; Mukhopadhyay P; Cope E
    Health Serv Res; 2018 Jun; 53(3):1430-1457. PubMed ID: 28560726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care policies/economics of the geriatric renal population.
    Eggers PW
    Am J Kidney Dis; 1990 Oct; 16(4):384-91. PubMed ID: 2121023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient selection in the Medicare End-Stage Renal Disease Program.
    de Lissovoy G
    Med Care; 1988 Oct; 26(10):959-70. PubMed ID: 3139942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quarter century of medicare expenditures for ESRD.
    Eggers PW
    Semin Nephrol; 2000 Nov; 20(6):516-22. PubMed ID: 11111852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription drugs in Medicare and the ESRD program.
    Powe NR
    Semin Nephrol; 2000 Nov; 20(6):535-42. PubMed ID: 11111855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare payment options for recombinant erythropoietin therapy.
    Sisk JE; Gianfrancesco FD; Coster JM
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):93-7. PubMed ID: 1928087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare program; end-stage renal disease prospective payment system. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2010 Aug; 75(155):49029-214. PubMed ID: 20712086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Washington: a nephrologist's perspective from inside the Beltway.
    Rubin RJ
    Am J Kidney Dis; 2013 Dec; 62(6):1042-5. PubMed ID: 24051080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saga of payment systems of ambulatory surgery centers for interventional techniques: an update.
    Manchikanti L; Singh V; Hirsch JA
    Pain Physician; 2012; 15(2):109-30. PubMed ID: 22430649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Dialysis and its Financing.
    Borelli M; Paul DP; Skiba M
    Hosp Top; 2016; 94(2):33-8. PubMed ID: 27315562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2017 Nov; 82(210):50738-97. PubMed ID: 29091373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health policy, disparities, and the kidney.
    Williams AW
    Adv Chronic Kidney Dis; 2015 Jan; 22(1):54-9. PubMed ID: 25573513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using race as a case-mix adjustment factor in a renal dialysis payment system: potential and pitfalls.
    Roach JL; Turenne MN; Hirth RA; Wheeler JR; Sleeman KS; Messana JM
    Am J Kidney Dis; 2010 Nov; 56(5):928-36. PubMed ID: 20888100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some of the small print on managed care proposals for end-stage renal disease.
    Hirth RA; Held PJ
    Adv Ren Replace Ther; 1997 Oct; 4(4):314-24. PubMed ID: 9356683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What can we learn from the U.S. expanded end-stage renal disease bundle?
    Chambers JD; Weiner DE; Bliss SK; Neumann PJ
    Health Policy; 2013 May; 110(2-3):164-71. PubMed ID: 23419419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.